Navigation Links
Claimsnet.com Reports Third Quarter 2008 Results
Date:10/30/2008

Including a 27% Increase in Revenues

DALLAS, Oct. 30 /PRNewswire-FirstCall/ -- Claimsnet.com inc. (OTC Bulletin Board: CLAI), a leading provider of Internet-based claims processing solutions for the healthcare industry, today reported its results for the third quarter of 2008, which ended September 30, 2008.

"We are pleased to report a 27% increase in our third quarter revenues," commented Don Crosbie, chief executive officer of Claimsnet. "The increase in overall costs during the third quarter of 2008 was due to the addition of new clearinghouse partners as well as customer support personnel. In addition, the costs of our renewed sales effort, with the two new sales personnel added in April 2008, is reflected in the higher costs when compared to last year. However, this renewed sales effort has resulted in new payer and provider contracts and continues to build a good pipeline of opportunities. We anticipate that this renewed investment in sales growth will positively impact the financial results in the next several quarters both in sales and operating results.

For the quarter ended September 30, 2008, Claimsnet reported revenues of $527,000, a 27% increase compared to the $414,000 reported for the third quarter of 2007. Revenues for the nine months ended September 30, 2008 were $1,545,000, a 25% increase compared to the $1,240,000 reported for the nine months of 2007.

Cost of revenues for the third quarter of 2008 was $408,000 compared to $274,000 for the third quarter of 2007, a 49% increase. Cost of revenues for the nine months of 2008 was $1,218,000 compared to $846,000 for the nine months of 2007, a 44% increase. Selling, general and administrative expenses of $245,000 were reported for the third quarter of 2008 compared to $195,000 reported for the third quarter of 2007. Selling, general and administrative expenses of $732,000 were reported for the nine months of 2008 compared to $594,000 reported for the nine months of 2007.

Claimsnet reported a gross profit of $119,000 for the third quarter of 2008, compared with a gross profit of $140,000 for the third quarter of 2007. Claimsnet reported a gross profit of $327,000 for the nine months of 2008, compared with a gross profit of $394,000 for the nine months of 2007.

The loss from operations for the third quarter of 2008 was $(126,000) compared to $(55,000) reported for the third quarter of 2007. The loss from operations for the nine months of 2008 was $(405,000) compared to $(200,000) reported for the nine months of 2007. The net loss for the third quarter of 2008 was $(151,000), or $(0.01) per share, compared to net loss of ($81,000), or $(0.00) per share, for the third quarter of 2007. The net loss for the nine months of 2008 was $(484,000), or $(0.02) per share, compared to net loss of ($275,000), or $(0.01) per share, for the nine months of 2007.

Claimsnet.com inc. is a leading provider of Internet-based claim processing solutions for the healthcare payer industry, including distinctive, advanced ASP technology. Headquartered in Dallas, Texas, Claimsnet offers systems that are distinguished by ease of use, customer care, security and measurable cost advantages. More information on Claimsnet can be found at the company's web site at http://www.claimsnet.com.

Safe Harbor Statement Under the Private Securities Litigation Act 1995 - With the exception of historical information, the matters discussed in this press release are forward looking statements that involve a number of risks and uncertainties. The actual future results of the company could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to, maintaining access to external sources of capital, regulatory actions, success of marketing strategies, actions of the company's competitors, dependence on suppliers and distribution channels, and continued use of the internet. Further information on the company's risk factors is contained in the company's quarterly, annual, and other periodic reports as filed with the Securities and Exchange Commission.

[Table to Follow]

CLAIMSNET.COM INC. AND SUBSIDIARIES

SUMMARY OPERATIONS STATEMENT INFORMATION

(In thousands except per share data)

(unaudited) (unaudited)

Quarter Ended Nine Months Ended

September 30, September 30,

-------------------- --------------------

2008 2007 2008 2007

------- ------- ------- -------

REVENUES $ 527 $ 414 $1,545 $1,240

COST OF REVENUES $ 408 $ 274 $1,218 $ 846

GROSS PROFIT $ 119 $ 140 $ 327 $ 394

SELLING, GENERAL

AND ADMINISTRATIVE $ 245 $ 195 $ 732 $ 594

LOSS FROM OPERATIONS $ (126) $ (55) $ (405) $ (200)

INTEREST INCOME $ - $ 1 $ - $ 6

INTEREST EXPENSE $ (25) $ (27) $ (79) $ (81)

NET LOSS $ (151) $ (81) $ (484) $ (275)

NET LOSS PER COMMON SHARE -

BASIC AND DILUTED $(0.01) $(0.00) $(0.02) $(0.01)

WEIGHTED AVERAGE COMMON

SHARES OUTSTANDING -

BASIC AND DILUTED 29,247 26,051 28,160 26,048


'/>"/>
SOURCE Claimsnet.com inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Claimsnet.com Reports First Quarter 2008 Results
2. Claimsnet.com Reports Fiscal Year 2007 Results
3. Remuda Ranch Reports Many Individuals With Eating Disorders Are Not Getting Help They Need
4. Palomar Medical Reports Financial Results for Third Quarter 2008
5. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
6. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
7. Orchid Cellmark Reports Third Quarter 2008 Financial Results
8. ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. Gentiva Reports Third Quarter Revenue and Profit Growth
10. LegalView Reports on Rare Traumatic Brain Injury Condition That Could Cause Complete Paralysis of A Victim
11. Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Northern Kentucky - Cincinnati, Ohio (PRWEB) , ... ... ... leader in the production of miniature, folded, pharmaceutical inserts and outserts. As ... & Serialization Device. This addition will enable Flottman to individually code professional ...
(Date:12/9/2016)... , ... December 09, 2016 , ... The Justin ... Dependence, Inc. (NCADD) is recommending the film Whispering Spirits and its ... District of Columbia as an education tool in the war against teen drug abuse. ...
(Date:12/9/2016)... ... ... An inventor from Cana, Va., wanted to fulfill the need for a ... , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates discrimination. It is ... in a matter of minutes, or even seconds. The SAFETY STRAP FOR AMPUTEES is ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy ... in New York, NY, on December 3rd, to benefit Holy Name Medical Center's ... annual event, which raised over $1 million - the largest event in the ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I had ... an inventor from Winchester, Va. "I thought that if the nebulizer had a more ... rather than fearing them." , He developed the patent-pending NEBY to avoid the need ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 MSD, a ... supply chain solutions to alternate site health care facilities, ... First Choice Medical Supply ("First Choice"), a privately held ... the skilled nursing and home health segments. We would ... This compelling transaction will deliver significant ...
(Date:12/9/2016)... -- Research and Markets has announced the addition ... report to their offering. ... Market growth can be attributed ... pharmaceutical and biotechnology industry and technological advancements like automation and ... and growing research activities in toxicology and stem cells provide ...
(Date:12/9/2016)... 9, 2016 Research and Markets has announced ... report to their offering. ... The global travel vaccines market to grow at a ... covers the present scenario and the growth prospects of the global ... report considers the revenue generated from the sales of various vaccines ...
Breaking Medicine Technology: